Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study

Abstract Brain metastases (BMs) are associated with poor prognosis in epidermal growth factor receptor mutation‐positive (EGFRm) non‐small cell lung cancer (NSCLC). Osimertinib is a third‐generation, irreversible, EGFR‐tyrosine kinase inhibitor that potently and selectively inhibits EGFR‐sensitizing...

Full description

Saved in:
Bibliographic Details
Main Authors: Simon Ekman (Author), Zsolt Cselényi (Author), Andrea Varrone (Author), Aurelija Jucaite (Author), Heather Martin (Author), Magnus Schou (Author), Peter Johnström (Author), Gianluca Laus (Author), Rolf Lewensohn (Author), Andrew P. Brown (Author), Jasper van derAart (Author), Karthick Vishwanathan (Author), Lars Farde (Author)
Format: Book
Published: Wiley, 2023-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available